Tian Ruixiang Holdings Ltd (TIRX)

USD 1.33

(8.13%)

EBITDA Summary of Tian Ruixiang Holdings Ltd

  • Tian Ruixiang Holdings Ltd's latest annual EBITDA in 2023 was -2.93 Million USD , up 36.35% from previous year.
  • Tian Ruixiang Holdings Ltd's latest quarterly EBITDA in 2024 Q1 was - USD , up 100.0% from previous quarter.
  • Tian Ruixiang Holdings Ltd reported an annual EBITDA of -4.73 Million USD in 2022, down -177.21% from previous year.
  • Tian Ruixiang Holdings Ltd reported an annual EBITDA of -1.99 Million USD in 2021, down -268.5% from previous year.
  • Tian Ruixiang Holdings Ltd reported a quarterly EBITDA of -2.89 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Tian Ruixiang Holdings Ltd reported a quarterly EBITDA of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual EBITDA Chart of Tian Ruixiang Holdings Ltd (2023 - 2017)

Historical Annual EBITDA of Tian Ruixiang Holdings Ltd (2023 - 2017)

Year EBITDA EBITDA Growth
2023 -2.93 Million USD 36.35%
2022 -4.73 Million USD -177.21%
2021 -1.99 Million USD -268.5%
2020 787.68 Thousand USD 111.25%
2019 137.38 Thousand USD -69.64%
2018 1.48 Million USD 35.03%
2017 1.12 Million USD 0.0%

Peer EBITDA Comparison of Tian Ruixiang Holdings Ltd

Name EBITDA EBITDA Difference
CorVel Corporation 121.35 Million USD 102.42%
eHealth, Inc. -9.15 Million USD 67.934%
Erie Indemnity Company 568.01 Million USD 100.517%
GoHealth, Inc. 24.1 Million USD 112.183%
Reliance Global Group, Inc. -8.92 Million USD 67.087%
Reliance Global Group, Inc. -8.92 Million USD 67.087%
Willis Towers Watson Public Limited Company 2.33 Billion USD 100.126%